Chester County News and Community Website
HARRISBURG, PA — Pennsylvania is expanding its statewide campaign to reduce the stigma surrounding substance use disorder by partnering with the Keystone Contractors Association, a move aimed at reaching an …
Pennsylvania Expands Addiction Recovery Campaign Into Construction Industry Read More
WASHINGTON, D.C. — Federal health officials backed the Drug Enforcement Administration’s move to begin temporarily placing certain kratom-related substances into Schedule I, escalating federal action against concentrated and synthetic products …
DEA Moves to Temporarily Schedule Kratom-Related Opioids Read More
PHILADELPHIA, PA — U.S. Customs and Border Protection officers in Philadelphia seized more than 32,000 unapproved prescription tablets shipped from Europe to an address in Spalding County, including tramadol, lorazepam, …
Feds Seize 32,000 Pills Hidden in ‘Gift’ Parcels Read More
CAMP HILL, PA — More than 400 substance use disorder professionals gathered this past week as Pennsylvania officials outlined new strategies to address a rapidly changing drug landscape and improve …
State Expands Fight Against Drug Crisis With New Strategies Read More
PENNSYLVANIA — A new national survey suggests that kratom, the once–trendy herbal extract marketed as a natural fix for pain and focus, may be losing its cultural shine. Thirty-nine percent …
Is Kratom the Next Public-Health Crisis? New Survey Reveals Pennsylvania’s Growing Alarm Read More
WASHINGTON, D.C. — In a sweeping regulatory move, the U.S. Food and Drug Administration (FDA) announced new safety labeling requirements for all prescription opioid pain medications, aiming to provide clearer …
FDA Orders Overhaul of Opioid Labels Amid New Evidence of Long-Term Risks Read More
WASHINGTON, D.C. — In a decisive step aimed at curbing the proliferation of potentially dangerous synthetic opioids, the U.S. Food and Drug Administration (FDA) announced recently that it is recommending …
FDA Moves to Restrict Potent Kratom Derivative 7-OH Amid Opioid Abuse Concerns Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has issued warning letters to seven companies accused of unlawfully marketing products containing 7-hydroxymitragynine (7-OH), a potent opioid compound derived …
FDA Targets 7-OH Kratom Products in Crackdown on Unapproved Opioid-Like Supplements Read More
MALVERN, PA — MAXONA Pharmaceuticals announced the formation of its Scientific Advisory Board (SAB) and the successful completion of its inaugural meeting, marking a significant milestone in the development of …
MAXONA Pharmaceuticals Advances Non-Opioid Pain Therapy with Launch of Scientific Advisory Board Read More
PHILADELPHIA, PA — This June, as we observe Post-Traumatic Stress Disorder (PTSD) Awareness Month, a convergence of anniversaries provides a solemn opportunity for reflection. In 2025, we will commemorate the …
The Unseen Scars of 250 Years of Service: PTSD and the Opioid Crisis Read More